Business
Multi-asset digital surgery and robotic ecosystem
Multi-asset digital surgery and robotic ecosystem.
About this update from Smith & Nephew Plc
[{"type":"text","content":"\n \nRNS Number : 6661S Smith & Nephew Plc 13 March 2019 \n\n \n \nSmith & Nephew establishes multi-asset digital surgery and robotic ecosystem \n \n13 March 2019\nSmith & Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces product launches and investments that establish its multi-asset digital surgery and robotic ecosystem. \nNamal Nawana, Chief Executive Officer, said: \n\"Smith & Nephew is making a long-term commitment to bring together advanced technologies in robotics, digital surgery, and machine learning as well as augmented reality to empower surgeons and improve clinical outcomes. Over time these digital surgery and robotic assets will be deployed across all surgical specialities and healthcare settings where Smith & Nephew's operates, starting with orthopaedic reconstruction and sports medicine.\"\nNAVIO◊ Surgical System \nCurrently in development, NAVIO 7.0 is the next version of Smith & Nephew's handheld robotic surgical system. NAVIO 7.0 is being designed to improve the surgeon experience through a new intuitive interface, expanded surgical preferences, and streamlined workflow which may reduce surgery time over the previous version. It will also bring the ANTHEM Total Knee System for Emerging Markets onto NAVIO. The NAVIO 7.0 demo is on show on Smith & Nephew's booth at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting 2019 (Las Vegas March 13-15), alongside a new virtual reality training module for robotics-assisted surgery developed for NAVIO by Osso VR.\nNAVIO 7.0 software has not been cleared by the FDA for distribution in the United States and is not yet commercially available, but is planned for the second half of 2019. \nNext generation robot announced \nDevelopment of Smith & Nephew's next generation surgical robotics platform is planned to be complete in late 2019, ahead of full commercial release in 2020. The platform dramatically reduces the physical footprint, enabling it to be incorporated into Smith & Nephew's sports medicine tower. This, together with its CT-free technology, makes it an ideal solution for all surgical settings, including ambulatory surgery centers (ASCs). Advances in surgical workflows, data acquisition and connectivity will ensure the platform is faster again than NAVIO 7.0...